Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | March 11, 2024 01:31pm

Gainers

  • Regencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares increased by 76.41% to $1.87. The company's market cap stands at $4.5 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares moved upwards by 28.1% to $1.96. The company's market cap stands at $21.8 million.
  • Graphite Bio (NASDAQ:GRPH) stock moved upwards by 25.47% to $3.94. The market value of their outstanding shares is at $229.4 million.
  • ASLAN Pharma (NASDAQ:ASLN) shares rose 24.8% to $0.78. The company's market cap stands at $13.0 million.
  • Mesoblast (NASDAQ:MESO) stock rose 22.79% to $2.64. The market value of their outstanding shares is at $267.9 million.

Losers

  • Lantern Pharma (NASDAQ:LTRN) shares declined by 22.8% to $6.38 during Monday's regular session. The company's market cap stands at $68.5 million.
  • Immuron (NASDAQ:IMRN) stock decreased by 19.48% to $3.06. The market value of their outstanding shares is at $17.4 million.
  • Ventyx Biosciences (NASDAQ:VTYX) stock declined by 18.82% to $8.05. The market value of their outstanding shares is at $477.1 million.
  • Intensity Therapeutics (NASDAQ:INTS) stock decreased by 15.74% to $4.5. The company's market cap stands at $61.6 million.
  • Poseida Therapeutics (NASDAQ:PSTX) stock decreased by 15.73% to $3.43. The company's market cap stands at $330.9 million. As per the press release, Q4 earnings came out 2 days ago.
  • NeuroOne Medical Tech (NASDAQ:NMTC) stock declined by 14.05% to $1.04. The company's market cap stands at $26.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ASLN BIAF GRPH IMRN INTS LTRN MESO NMTC PSTX RGC TCBP VTYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist